QLI

Q: What is the price of Qilian International Holding Group (QLI) today?

The current price of Qilian International Holding Group (QLI) is $ 0.00, representing a 0% gain over the past year. The stock began the year trading around $ 0.00 and is currently priced at $ 0.00. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does Qilian International Holding Group (QLI) pay dividends?

Qilian International Holding Group (QLI) did not pay dividends over the past year.

Qilian International Holding Group Limited

Price

$ -

return (12m)

0.00%

p/e

308.85

p/bv

4.52

DIVIDEND YIELD

0.00%

QLI price

QLI

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment QLI

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals QLI

review the fundamentals of Qilian International Holding Group shares

P/E

308.85

Sector: -2.29 Industry: -5.62

P/S (PSR)

Sector: 1.99 Industry: 2.92

P/BV

4.52

Sector: 2.18 Industry: 2.12

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

1.22%

Sector: -26.05% Industry: -48.74%

ROE

1.46%

Sector: -29.81% Industry: -41.50%

ROIC

Sector: -416.93% Industry: -485.80%

NET MARGIN

0.00%

Sector: -28.23% Industry: -32.27%

GROSS MARGIN

0.00%

Sector: 44.66% Industry: 45.26%

OPERATING MARGIN

0.00%

Sector: -23.34% Industry: -27.83%

EV/EBITDA

84.89

Sector: -0.62 Industry: -2.47

EV/EBIT

135.52

Sector: -1.80 Industry: -4.30

PRICE-TO-ASSETS

3.77

Sector: 1.17 Industry: 1.27

BVPS

1.20

Sector: 3.79 Industry: 2.16

EPS

0.02

Sector: -0.90 Industry: -1.33

EQUITY-TO-ASSETS RATIO

0.83

Sector: 0.43 Industry: 0.49

LIABILITIES / ASSETS

0.83

Sector: 0.46 Industry: 0.42

CAGR REVENUE 5 YEARS

0.00%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

-20.89%

Sector: - Industry: -

FAIR VALUE OF Qilian International Holding Group ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$ 0.00

Fair Value

$ 0.00

Upside/Downside Return potential.

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals QLI

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
LLY	40.20	34.79	86.53%	0.67%	$ 829.69 B	31.66%
ISRG	58.32	9.28	15.92%	0.00%	$ 166.57 B	28.38%
TMO	29.53	3.70	12.52%	0.33%	$ 198.00 B	15.05%
SNY	12.86	1.40	10.86%	4.60%	$ 117.31 B	18.68%
NVS	20.81	6.25	30.04%	4.59%	$ 291.02 B	24.67%
ABT	27.37	3.48	12.73%	2.34%	$ 178.54 B	14.72%
MDT	23.97	2.25	9.38%	3.30%	$ 110.58 B	13.00%
GSK	15.37	5.49	35.71%	3.00%	$ 117.24 B	17.48%
CVS	55.53	1.30	2.35%	3.44%	$ 98.17 B	0.44%
BSX	32.87	0.00	0.00%	0.00%	$ 95.25 B	14.44%
TMDX	20.70	8.33	40.22%	0.00%	$ 3.94 B	31.43%
HCA	16.40	-40.15	-244.82%	0.60%	$ 111.26 B	8.97%
IDXX	44.49	29.36	65.99%	0.00%	$ 47.14 B	24.62%
RMD	22.41	5.27	23.51%	1.02%	$ 33.31 B	27.53%
DHR	38.10	2.62	6.88%	0.66%	$ 137.69 B	14.71%
INMD	9.84	1.35	13.73%	0.00%	$ 922.95 M	25.32%
PHG	27.23	2.20	8.06%	2.98%	$ 28.25 B	5.07%
FMS	11.87	0.80	6.75%	3.36%	$ 13.40 B	5.02%
SYK	40.51	5.86	14.48%	0.99%	$ 131.49 B	12.92%

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

QLI Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	02/28/2023	03/06/2023	0,25000000

ABOUT Qilian International Holding Group

Qilian International Holding Group Limited

Average Investor10 user rating

4.0 (0 people)

United States

7 years

Founded: 2019

2021

Time since IPO - 5 years

292

Employees

Qilian International Holding Group Limited (United States) is listed on the Nasdaq and has a market capitalization of $193.41 Millions, with shareholders equity totaling $42.79 Millions.

The company employs approximately 292 people and operates in the Health sector, within the Pharmaceutical Products industry.

Over the past 12 months, Qilian International Holding Group Limited reported $- in revenue, generating net income of $626.21 Thousand.

Key financial metrics include a P/E ratio of 308.85, a price-to-book (P/B) ratio of 4.52, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker QLI.

Market cap

$ 193.41 Millions

Net worth

$ 42.79 Millions

$ 42,792,133.00

Assets

$ 51.26 Millions

$ 51,257,994.00

Total Shares Outstanding

35.75 Millions

35,750,000

Average Daily Trading Volume

$ 26.92 Thousand

$ 26,916.80

Sector

Health

Industry

Pharmaceutical Products

QLI

QLI revenue and profits

Financial Results QLI

DRAG THE FRAME TO SEE MORE DATA

QLI cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

LBPSW - 4D pharma

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-300.00%

P/BV

0.00

CVS - CVS Health

$ 77.36 23,77% (12M)

P/E

55.53

3.44%

ROE

2.35%

P/BV

1.30

CI - Cigna

$ 276.69 --16,18% (12M)

P/E

10.79

2.19%

ROE

0.00%

P/BV

0.00

CNC - Centene

$ 39.14 --35,02% (12M)

P/E

-2.81

0.00%

ROE

-33.28%

P/BV

0.94

HUM - Humana

$ 217.36 --14,45% (12M)

P/E

20.72

1.73%

ROE

6.70%

P/BV

1.39

HCA - HCA Healthcare

$ 471.18 46,14% (12M)

P/E

16.40

0.60%

ROE

-244.82%

P/BV

-40.15

LLY - Eli Lilly

$ 903.02 9,67% (12M)

P/E

40.20

0.67%

ROE

86.53%

P/BV

34.79

NVS - Novartis

$ 147.97 40,29% (12M)

P/E

20.81

4.59%

ROE

30.04%

P/BV

6.25